Kelly R. Thornburg
Corporate Officer/Principal chez CHIMERIC THERAPEUTICS LIMITED
Profil
Kelly R.
Thornburg is currently the Vice President & Head-Quality at Chimeric Therapeutics Ltd.
(Australia) since 2022.
Previously, Thornburg worked as an Executive Director-Quality at Amgen, Inc. and as the Head-US Commercial Manufacturing at Kite Pharma, Inc. Thornburg also served as the Senior Vice President-Operations at XBiotech, Inc. from 2015 to 2017.
Thornburg obtained an undergraduate degree from Rockhurst University.
Postes actifs de Kelly R. Thornburg
| Sociétés | Poste | Début |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03/02/2022 |
Anciens postes connus de Kelly R. Thornburg
| Sociétés | Poste | Fin |
|---|---|---|
| XBIOTECH INC. | Directeur des opérations | 05/05/2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
